Related Experiment Video
Updated: Jun 17, 2026
09:54
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Transfusion-related acute lung injury
1Histocompatibility Laboratory, BloodSource, 10536 Peter A McCuen Blvd, Mather, CA 95655, USA.
Summary
Transfusion-related acute lung injury (TRALI) is a severe complication occurring within 6 hours of blood transfusion, often linked to white blood cell antibodies. Current measures aim to mitigate this leading cause of transfusion mortality.
Area of Science:
- Hematology
- Immunology
- Critical Care Medicine
Background:
- Transfusion-related acute lung injury (TRALI) is a critical clinical syndrome following blood product administration.
- It is the primary cause of mortality associated with blood transfusions.
- TRALI manifests with acute respiratory distress and pulmonary edema within six hours of transfusion.
Purpose of the Study:
- To outline the clinical presentation and pathophysiology of TRALI.
- To describe current treatment strategies for TRALI.
- To inform about risk reduction measures being implemented by blood centers.
Main Methods:
- Clinical case review and analysis of transfusion reactions.
- Review of immunological mechanisms involving antibodies to leukocyte antigens.
- Examination of blood banking protocols and safety measures.
Main Results:
- TRALI is characterized by rapid onset of respiratory failure, pulmonary edema, and hemodynamic instability.
- The syndrome is frequently associated with donor-derived antibodies targeting recipient white blood cells.
- Standard treatment involves supportive care, including respiratory support and hemodynamic management.
Conclusions:
- TRALI represents a significant risk in transfusion medicine, necessitating vigilant monitoring and management.
- Understanding the immunological basis of TRALI is crucial for developing effective prevention strategies.
- Blood centers are actively implementing measures to reduce the incidence of TRALI, safeguarding transfusion recipients.
Related Concept Videos
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:21Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:26Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
01:23Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...